Related Experiment Videos

Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation

Paul Kubes1, Derrice Payne, Richard C Woodman

  • 1Immunology Research Group, Department of Physiology and Biophysics and Department of Medicine, University of Calgary Health Sciences Center, Calgary, Alberta, Canada T2N 4N1. pkubes@ucalgary.ca

Insights

Leukocyte recruitment in liver ischemia-reperfusion (I/R) inflammation relies on adhesion molecules, not selectins. Anti-adhesion therapy effectively targets leukocyte infiltration in liver sinusoids during I/R.

Area of Science:

  • Immunology
  • Hepatology
  • Vascular Biology

Background:

  • Leukocyte recruitment into liver sinusoids typically bypasses selectin-dependent mechanisms.
  • Liver ischemia-reperfusion (I/R) presents a unique inflammatory exception where selectins may play a role.

Purpose of the Study:

  • To investigate the role of selectins and adhesion molecules in leukocyte recruitment during liver I/R.
  • To evaluate the efficacy of anti-selectin and anti-adhesion therapies in liver I/R models.

Main Methods:

  • Intravital microscopy to visualize liver microcirculation during I/R and endotoxemia.
  • Administration of anti-selectin (fucoidan) and anti-adhesion (hirudin) therapies.
  • Surgical manipulation to isolate the liver from intestinal ischemia effects.

Main Results:

  • Selectin-blocking therapy (fucoidan) inhibited neutrophil rolling but not adhesion in liver sinusoids during I/R.
  • Anti-adhesion therapy (hirudin) effectively reduced leukocyte adhesion in postsinusoidal venules and sinusoids during I/R.
  • Even after removing the intestine, leukocyte adhesion persisted in sinusoids during liver I/R, suggesting selectin-independent mechanisms.

Conclusions:

  • Leukocyte recruitment in liver I/R is primarily mediated by selectin-independent adhesion pathways.
  • Anti-adhesion therapy demonstrates significant efficacy in mitigating leukocyte infiltration in the liver during I/R.
  • Targeting adhesion molecules offers a promising therapeutic strategy for liver I/R injury, potentially independent of upstream intestinal effects.

Related Concept Videos